Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
about
The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic reviewPregnancy-Associated Changes in Pharmacokinetics: A Systematic ReviewKnowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western KenyaEffect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant womenPopulation pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.Treating severe malaria in pregnancy: a review of the evidenceAnti-infective use in children and pregnancy: current deficiencies and future challenges.Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsArtemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.Treatment regimens for pregnant women with falciparum malaria.The application of physiologically-based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges.Developmental toxicity studies of lumefantrine and artemether in rats and rabbits.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infectionAnimal Embryotoxicity Studies of Key Non-Artemisinin Antimalarials and Use in Women in the First TrimesterDevelopments in Taste-Masking Techniques for Traditional Chinese Medicines
P2860
Q28079877-3C416729-3766-4F66-9455-56E4F62C496EQ28109657-FFFD6A1A-FAA5-4E2D-AECE-89118FABFB2FQ28552671-38B7628A-3B89-48B2-87D9-0185A9746FECQ33869119-26CC9185-05CE-4CAD-9FEC-7E628E6EA818Q34331026-A4F79765-9740-4AE5-B0E0-B1D7A4D65823Q34456393-4B8E2EB7-8AF9-46F2-B42B-28A27B6B4946Q35023696-6653CDD0-8CFD-412D-B8A5-63747129E60BQ35286119-CED8B66F-6DF9-4595-B9BA-BD0926163786Q36644765-13250128-F739-4302-8E6A-1664080B60F7Q36898678-C96A1FD9-6097-416C-AD9A-2DC5ABC12DD5Q38870452-25D6D217-8EF8-4246-958B-0B1A9DFA4FEAQ40133890-E21342F5-792F-4C13-976E-235596EB52E4Q46405195-00B34DBC-AB70-4DFB-963C-C2DD829DAE06Q47244112-A0B35110-7EF9-420B-BA31-D91A0DD9B068Q47982459-0B78A838-B8B3-4C03-A888-D7FD80D27428Q55449589-C57F2C63-E838-465C-A8BD-6F8FE5F724C2Q56346858-8C4193BD-1009-4A4F-A3A4-00F10BDCD273Q56428696-544C1062-5B80-483B-8A29-D748C8C91C92Q58745615-B36EEC61-61D6-462C-9614-135518FBD238
P2860
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@en
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@nl
type
label
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@en
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@nl
prefLabel
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@en
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@nl
P2093
P2860
P50
P921
P356
P1476
Pharmacokinetic properties of ...... falciparum malaria in Uganda.
@en
P2093
Mehul Dhorda
Patrice Piola
Vincent Jullien
P2860
P304
P356
10.1128/AAC.00683-13
P407
P577
2013-08-05T00:00:00Z